UNSPSC 51282528: Cefatrizine propylene glycol

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N6O5S2.C3H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3731IA5GI9, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-5-ylthio)methyl)-, (6r,7r)-, compd. with 1,2-propanediol (1:1), but more generally known as cefatrizine propylene glycol, which bears US NIH Compound Identifier 6410757.

European Medicines Agency schedules cefatrizine propylene glycol or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07376MIG. Most nations, for tariff purposes, schedule cefatrizine propylene glycol under HS 29419000. SMILES: CC(CO)O.C1CC(CCC1[C@H](C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4CNN[NH]4)C(=O)O)N)O.

UNSPSC 51282528 Cefatrizine propylene glycol is a Commodity code nominally identifying a specific pharmaceutical product, but the recent state and local opportunities tagged to this code do not align with cefatrizine procurement. Instead, the tagged solicitations show state and local health agencies buying naloxone, drug deactivation systems, and other pharmaceutical products through competitive bidding and cooperative purchasing vehicles. The code's recent activity reflects acquisition of emergency medical and public health pharmaceuticals through warehouse and direct-supply contracts, typically in multi-unit annual orders with renewal options and quarterly or on-demand delivery schedules.

Issuing bodies using this code include state departments of public health and county health authorities. Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 for $2.999 million over three years (12 months initial plus two renewal options) through the MMCAP Infuse consortium, sourcing Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets via an Invitation for Bid process. Seminole County, Florida released an IFB (IFB60459723LAS) with a due date of July 26, 2023 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term with one-year renewal option. Activity centers on Florida and Illinois; the mismatch between the code's nominal scope (cefatrizine) and the actual work being solicited (naloxone, doxycycline, ciprofloxacin, and drug deactivation systems) suggests the code may be misapplied in the state and local procurement system or that this particular commodity code sees limited activity aligned with its definition.